Insider · CIK 0001826131
Roger Michael Gendreau
Files at DWTX (Dogwood Therapeutics, Inc.). First filing -, latest -.
In brief
Roger Michael Gendreau files SEC Form 4 as officer at DWTX (Dogwood Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Roger Michael Gendreau has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | DWTX Dogwood Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +82,500 | $0.00 | $0 | 82,500 | Mar 6, 2026 |
| Dec 4, 2025 | DWTX Dogwood Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +150,000 | $0.00 | $0 | 150,000 | Dec 5, 2025 |
| Jun 27, 2025 | DWTX Dogwood Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +12,075 | $0.00 | $0 | 12,075 | Jul 1, 2025 |
Questions about Roger Michael Gendreau
Answered from the filings on this page, as of the latest one.
Is Roger Michael Gendreau buying or selling?
Roger Michael Gendreau has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Roger Michael Gendreau's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Roger Michael Gendreau has 0.
Where does Roger Michael Gendreau file Form 4?
Roger Michael Gendreau has filed Form 4 at DWTX (Dogwood Therapeutics, Inc.) as CHIEF MEDICAL OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.